Prakasam Ramachandran, Determan Julianna, Narasimhan Mishka, Shen Renata, Saleh Maamoon, Chapman Gareth, Kaushik Komal, Gontarz Paul, Meganathan Kesavan, Hakim Bilal, Zhang Bo, Huettner James E, Kroll Kristen L
bioRxiv. 2024 Sep 12:2024.09.11.612541. doi: 10.1101/2024.09.11.612541.
MYT1L is a neuronal transcription factor highly expressed in the developing and adult brain. While pathogenic mutation causes neurodevelopmental disorders, these have not been characterized in human models of neurodevelopment. Here, we defined the consequences of pathogenic mutation in human pluripotent stem cell-derived cortical interneurons. During differentiation, mutation reduced MYT1L expression and increased progenitor cell cycle exit and neuronal differentiation and synapse-related gene expression, morphological complexity, and synaptic puncta formation. Conversely, interneuron maturation was compromised, while variant neurons exhibited altered sodium and potassium channel activity and reduced function in electrophysiological analyses. CRISPRi-based knockdown similarly impaired interneuron differentiation and maturation, supporting loss of function-based effects. We further defined MYT1L genome-wide occupancy in interneurons and related this to the transcriptomic dysregulation resulting from mutation, to identify direct targets that could mediate these phenotypic consequences. Together, this work delineates contributors to the etiology of neurodevelopmental disorders resulting from mutation.
MYT1L是一种在发育中的大脑和成年大脑中高度表达的神经元转录因子。虽然致病性突变会导致神经发育障碍,但这些障碍在神经发育的人类模型中尚未得到表征。在这里,我们确定了人类多能干细胞衍生的皮质中间神经元中致病性突变的后果。在分化过程中,突变降低了MYT1L的表达,增加了祖细胞周期退出,并增加了神经元分化和突触相关基因的表达、形态复杂性和突触小体形成。相反,中间神经元的成熟受到损害,而变异神经元在电生理分析中表现出钠和钾通道活性改变以及功能降低。基于CRISPRi的敲低同样损害了中间神经元的分化和成熟,支持基于功能丧失的效应。我们进一步确定了MYT1L在中间神经元中的全基因组占有率,并将其与突变导致的转录组失调相关联,以确定可能介导这些表型后果的直接靶点。总之,这项工作描绘了由突变导致的神经发育障碍病因的相关因素。